bioAffinity Technologies, Inc. Common Stock (BIAF) is a publicly traded Healthcare sector company. As of November 6, 2026, BIAF trades at $2.52 with a market cap of $1.56M and a P/E ratio of -0.83. BIAF moved +0.00% today. Year to date, BIAF is -85.31%; over the trailing twelve months it is -91.04%. Its 52-week range spans $2.54 to $697.95. Rallies surfaces BIAF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $2.52 |
| Market Cap | $1.56M |
| P/E Ratio | -0.83 |
| EPS | $-7.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $697.95 |
| 52-Week Low | $2.54 |
| Volume | 17.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.90M |
| Net Income | $-15.19M |
| Gross Margin | 0.00% |
BIAF analyst coverage data. Average price target: $0.00.